Senior Product Manager

Nucs AI is revolutionizing cancer care through AI and medical imaging technology, focusing on diagnostics and treatment planning in oncology, partnering with medical institutions worldwide.

Location: United States

Responsibilities

• Own the roadmap for one or more product lines (e.g., DeepPSMA, SelectPSMA, TrackPSMA), balancing clinical impact, technical feasibility, and business value.
• Engage directly with clinicians, nuclear medicine physicians, and oncologists to understand workflows, pain points, and decision-making processes.
• Translate ambiguous, technically complex problems into well-structured product requirements and clear success criteria.
• Develop and articulate a clear product narrative: why this feature matters, who it serves, and how it connects to the broader platform vision.
• Navigate the regulatory landscape (FDA, CE marking) as a stakeholder, understanding how regulatory requirements shape product decisions and timelines.
• Drive cross-functional execution with engineering, AI/ML, clinical, regulatory, and commercial stakeholders, keeping a small team moving fast without sacrificing quality.
• Contribute to go-to-market strategy, positioning, and customer enablement alongside commercial and clinical teams.
• Define and track meaningful product metrics; use data and user feedback to inform iteration and prioritization decisions.

Requirements

• 3-6 years of product management experience in a B2B or technical environment building products for specialized, professional users.
• Demonstrated ability to manage complex products where the user base has deep domain expertise.
• Strong conceptual and systems thinking.
• Startup or high-growth experience.
• Excellent communication skills.
• Comfort with technical depth.
• Intellectual curiosity and learning agility.
• Fluency in English (native or professional proficiency required - C1 level or higher).

Benefits

• Mission with real impact – Your work directly improves how cancer patients are diagnosed and treated.
• Ground-floor opportunity – Early-stage company, meaningful equity, and outsized influence on the direction we take.
• World-class collaborators – Work alongside leading oncologists, nuclear medicine physicians, and AI researchers globally.
• Massive market tailwinds – Radioligand therapy and AI-driven oncology are multi-billion dollar growth markets.
• Autonomy and flexibility – Remote-first, flexible working.
• Equity upside – Competitive equity package.